Costs for generic hepatitis C drugs in India paid back in 5 years
7 June 2017 | By Niamh Marriott, Junior Editor
Treatment with generic directly-acting antiviral drugs available in India increases lifespan while reducing lifetime health care costs
List view / Grid view
News
Biosimilar trastuzumab candidate shown similar in efficacy and safety
7 June 2017 | By Niamh Marriott, Junior Editor
Data has shown similarity in efficacy and safety between CT-P6 (biosimilar trastuzumab candidate) and reference trastuzumab treatment in patients...
Hands-on lateral flow test development workshop
6 June 2017 | By BBI Solutions
BBI Solutions, in partnership with Merck and Kinematic Automation, is hosting a lateral flow seminar designed to provide a practical insight into lateral flow test development...
ViiV Healthcare submits regulatory applications for HIV two-drug regimen
6 June 2017 | By Niamh Marriott, Junior Editor
Regulatory submissions to the EMA and FDA for a single-tablet, two-drug regimen of dolutegravir & rilpivirine for the maintenance treatment of HIV...
FDA approves Roche’s lung cancer companion diagnostic
6 June 2017 | By Niamh Marriott, Junior Editor
The FDA have approved Roche’s VENTANA ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer (NSCLC) patients...
Sanofi and Boehringer Ingelheim confirm closing of business swap date
6 June 2017 | By Niamh Marriott, Junior Editor
The strategic transaction, which consists of an exchange of Sanofi's animal health business & Boehringer Ingelheim's CHC business, has been closed in market
Saratha Rajeswaran joins ABPI as Executive Director
2 June 2017 | By Niamh Marriott, Junior Editor
Sara Rajeswaran has joined the Association of the British Pharmaceutical Industry as the new Executive Director of Government Affairs and Devolved Nations.
ESMO welcomes the adoption of the 2017 WHO Cancer Resolution
2 June 2017 | By Niamh Marriott, Junior Editor
ESMO welcomes the adoption of cancer resolution on prevention and control in the context of an integrated approach during the 70th World Health Assembly...
EMA to review Sandoz biosimilars adalimumab and infliximab
Sandoz announced that the EMA has accepted for regulatory review for biosimilars to AbbVie's Humira (adalimumab) and Janssen's Remicade (infliximab)...
First treatment for 5q spinal muscular atrophy approved by EU
1 June 2017 | By Niamh Marriott, Junior Editor
The EC has granted marketing authorisation for Ionis Pharmaceuticals’ Spinraza (nusinersen) for the treatment of 5q spinal muscular atrophy (SMA)...
Aptar Pharma’s electronic lockout device approved by EMA
1 June 2017 | By Niamh Marriott, Junior Editor
The European Medicines Agency (EMA) has approved Aptar Pharma’s integrated electronic nasal lockout device (e-Lockout) following a partnership with Takeda.
Atlantic develops tablet formulations of alicaforsen to treat Crohn’s disease
1 June 2017 | By Niamh Marriott, Junior Editor
Atlantic Healthcare announces the development of two separate tablet formulations of alicaforsen, for targeted delivery in the GI tract...
Emblem acquires land in preparation for the cannabis market
1 June 2017 | By Niamh Marriott, Junior Editor
Emblem has agreed to purchase land in preparation for the anticipated demand stemming from the proposed legalisation of adult recreational use in Canada...
New EMA guidelines on biosimilar medicines
1 June 2017 | By Niamh Marriott, Junior Editor
The European Medicines Agency (EMA) and the European Commission have published an information guide for healthcare professionals on biosimilar medicines...
Studying century-old drug as potential new approach to autism
31 May 2017 | By Niamh Marriott, Junior Editor
In a small, randomised Phase I/II clinical trial, researchers at UC San Diego School of Medicine say a 100-year-old drug called suramin...
